Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/04/1990 | US4975445 Antidepressants |
12/04/1990 | US4975444 Cycloalkyl-substituted glutaramide antihypertensive agents |
12/04/1990 | US4975437 Isomers of 1-azabicyclo(2.2.2)oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate |
12/04/1990 | US4975436 Treatment of anxiety |
12/04/1990 | US4975435 Certain 1H-pyrrold[3,4-b]quinolin-1-one-9-amino-2,3-dihydro derivatives useful for treating anxiety |
12/04/1990 | US4975432 Improved blood flow |
12/04/1990 | US4975430 CNQX and its analogs as therapeutics for degenerative neural diseases |
12/04/1990 | US4975428 Treatment of glaucoma using phosphodiesterase inhibitors |
12/04/1990 | US4975427 17-sulfur-20,21-dinor-eburnamenines |
12/04/1990 | US4975426 Cough/cold mixtures comprising non-sedating antihistamine drugs |
12/04/1990 | US4975418 Therapeutically active compositions of pseudo-peptide of glutamyl-aspartic acid |
12/04/1990 | US4975372 Culturing actinomycetes in presence of 1-683,590 under aerobic fermentation |
12/04/1990 | US4975370 Process for preparing 14-hydroxy-6-O-methyl-erythromycin A |
12/04/1990 | US4975368 Anticarcogenic agents |
12/04/1990 | US4975283 Mixing with glutamic acid hydrochloride |
12/04/1990 | US4975281 Agent forming protective complex in acid environment and alkaline material; preventing formation in and adherence to mouth |
12/04/1990 | US4975279 7-oxabicycloheptane substituted diamide prostaglandin before, during or after attack |
12/04/1990 | US4975271 Muscosal delivery systems for treatment of periodontal disease |
12/04/1990 | US4975269 Shelf stable aspirin solutions |
12/04/1990 | US4975217 Organic acid and alkyl sulfonate salt |
12/04/1990 | US4975109 Bactericide, fungicide and algaecide |
12/04/1990 | CA1277332C Phenyl nonatetraenoic acid derivatives |
12/04/1990 | CA1277330C Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them |
12/04/1990 | CA1277329C Dioxane hexenoic acids |
12/04/1990 | CA1277326C Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity |
12/04/1990 | CA1277325C Synthesis of nizatidine |
12/04/1990 | CA1277323C Thiazolidinedione derivatives, their production and use |
12/04/1990 | CA1277322C Antihypertensive reduced pyridyl derivatives |
12/04/1990 | CA1277321C Nitrataolkyl 1,4-benzodioxane derivatives |
12/04/1990 | CA1277320C 2-phenylbenzoxepin derivative |
12/04/1990 | CA1277319C 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs |
12/04/1990 | CA1277318C Oxicam derivatives as inhibitors of 5-lipoxygenase |
12/04/1990 | CA1277316C 1,5-benzothiazepine compounds |
12/04/1990 | CA1277315C Benzothiazepine derivatives |
12/04/1990 | CA1277313C Method for producing chemical compounds |
12/04/1990 | CA1277274C Plasma expander based on starch |
12/04/1990 | CA1277241C Composition and method for reducing wrinkles |
12/04/1990 | CA1277240C Medicament used as immunity modulator and process for its preparation |
12/04/1990 | CA1277239C Treatment of diseases caused by retroviruses |
12/04/1990 | CA1277233C Kit for use in the treatment of osteoporosis |
12/04/1990 | CA1277232C Methods and compositions for the treatment of gastrointestinal disorders |
12/04/1990 | CA1277174C Feed additive for improving growth in agricultural animals |
12/03/1990 | WO1990014830A1 Pharmaceutical composition and method of inhibiting virus |
12/03/1990 | WO1990014829A1 Lysolecithin derivatives for treating autoimmune diseases |
12/03/1990 | CA2030803A1 Pharmaceutical composition and method of inhibiting virus |
12/03/1990 | CA2018036A1 P-substituted propane-phosphinic acid compounds |
12/02/1990 | CA2018133A1 Use of xylan polyhydrogensulfates for the therapy of disorders based on cell proliferation |
12/02/1990 | CA2018102A1 Avermectin-3,4-oxide derivatives useful as antiparasitic agents and insecticides |
12/02/1990 | CA2018101A1 Avermectin derivatives |
12/02/1990 | CA2018097A1 Avermectin derivatives |
12/02/1990 | CA2018096A1 Parenteral nutrition product |
12/02/1990 | CA2017966A1 Amines |
12/02/1990 | CA2017961A1 Chromanderivatives |
12/02/1990 | CA2017959A1 Intravenous solutions with a rapid onset of action |
12/02/1990 | CA2017897A1 Bephenyl derivatives, process for preparing the same and intermediates therefor |
12/02/1990 | CA2017156A1 Preparation of fr115224 substance for parenteral administration |
12/02/1990 | CA2016465A1 Method for preventing or treating anxiety employing a calcium channel blocker |
12/02/1990 | CA2016464A1 Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof |
12/01/1990 | WO1990015056A1 Dopamine agonists |
12/01/1990 | CA2056995A1 Dopamine agonists |
12/01/1990 | CA2018103A1 Angiotensin ii antagonists |
12/01/1990 | CA2017987A1 Oxidizing agents as systemic (parenteral) pharmaceuticals |
12/01/1990 | CA2017957A1 2 hydroxy-n-propylamines, pharmaceutical compositions containing these compounds and processes for the preparation thereof |
12/01/1990 | CA2017911A1 4,5,6,11-tetrahydrobenzo [6,7] -cycloocta [1,2-b] thiophen-6,11-imines and 6,11-dihydrobenzo [6,7] -cycloocta [1,2-b] thiophen-6,11 imines |
12/01/1990 | CA2017903A1 Acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
12/01/1990 | CA2017781A1 Method of treatment of ischemia in brain |
12/01/1990 | CA2017596A1 Agents for treatment of brain ischemia |
11/30/1990 | CA2017773A1 Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists |
11/30/1990 | CA2017648A1 Active compounds |
11/30/1990 | CA2017625A1 Method and composition for treating protozoal infections with a novel antibacterial agent |
11/30/1990 | CA2017044A1 Pyrrolidone derivatives, process for their preparation and pharmaceutical composition containing same |
11/29/1990 | WO1990014354A1 STEROIDS WITH A 9α-HYDROXY-19,11β BRIDGE, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
11/29/1990 | WO1990014352A1 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives |
11/29/1990 | WO1990014340A1 Glutamic acid derivatives |
11/29/1990 | WO1990014338A1 Anti-inflammatory 4-aminophenol derivatives |
11/29/1990 | WO1990014334A1 N-PHENYLALKYL SUBSTITUTED α-AMINO CARBOXAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
11/29/1990 | WO1990014330A1 Novel 8-substituted-2-aminotetralines |
11/29/1990 | WO1990014329A1 Leukotriene b4 derivatives, process for producing them and their use as drugs |
11/29/1990 | WO1990014090A1 SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE |
11/29/1990 | WO1990014088A1 2-piperidino-1-alkanol derivatives as antiischemic agents |
11/29/1990 | WO1990014087A1 2-piperidino-1-alkanol derivatives as antiischemic agents |
11/29/1990 | WO1990014086A1 Utilisation of acridine derivatives in the treatment of retroviral infections in humans |
11/29/1990 | WO1990014085A1 Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition |
11/29/1990 | WO1990014084A1 Use of melatonin derivatives for effecting contraception |
11/29/1990 | WO1990014083A1 Composition and method for neural desensitization |
11/29/1990 | WO1990014082A1 Retinoic acid-based aqueous gel |
11/29/1990 | WO1990014077A1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS |
11/29/1990 | WO1990014075A1 Osmotic dosage form |
11/29/1990 | WO1990014073A1 Pharmaceutical preparation |
11/29/1990 | WO1990014008A1 Methods and compositions for inhibiting tumor cell growth |
11/29/1990 | WO1990011758A3 Use of a potassic agonist in the treatment of glaucoma |
11/29/1990 | WO1990010448A3 Covalent conjugates of lipid and oligonucleotide |
11/29/1990 | WO1990005524A3 Pharmaceutical compositions for neuro protection containing arylcyclohexylamines |
11/29/1990 | DE3917268A1 New ergoline di:ethyl-urea derivs. |
11/29/1990 | CA2033187A1 Leukotriene-b derivatives, process for their production and their use as pharmaceutical agents |
11/29/1990 | CA2017680A1 Method for enhancing the cytotoxicity of anthracyclines through photoactivation |
11/29/1990 | CA2017604A1 Pyrrolopyrimidines, their production and use |
11/28/1990 | EP0399982A1 Novel 8-substituted-2-amino-tetralines |
11/28/1990 | EP0399949A1 Substituted aminoalkylphosphinic acids |
11/28/1990 | EP0399909A1 Cosmetic composition against skin ageing |